David Alker
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David Alker.
Tetrahedron-asymmetry | 1990
David Alker; Kevin J. Doyle; Laurence M. Harwood; Andrew McGregor
Abstract The preparation of the cyclic sulphamidate of (S)-prolinol has been achieved by reaction with sulphuryl chloride at low temperature. This material has been shown to be susceptible to acid catalysed nucleophilic attack to furnish 2-(NN-dialkylamino)methyl- and 2-(methoxymethy]pyrrolidines after hydrolysis of the intermediate sulphamic acid derivatives.
Tetrahedron | 1998
David Alker; Giles Hamblett; Laurence M. Harwood; Sarah M. Robertson; David J. Watkin; C.Eleri Williams
Abstract Chiral stabilised azomethine ylids derived from the reaction of (5S)-5-phenylmorpholin-2-one (1) with aldehydes undergo efficient and highly diastereocontrolled cycloaddition with a second molecule of aldehyde to furnish products (2) which may be converted into enantiomerically pure threo (2S,3R) β-hydroxy-α-amino acids (3) in excellent yield.
European Journal of Medicinal Chemistry | 1991
David Alker; John Edmund Arrowsmith; Simon F. Campbell; Peter E. Cross
Abstract The preparation of a range of 1,4-dihydropyridine analogues of amlodipine has been undertaken and their calcium antagonist activities on rat aorta have been evaluated. Increasing the size of the C5 ester group dramatically reduces calcium antagonist activity, a trend which would be compatible with the carbonyl group of that ester binding to the DHP receptor. Amlodipine analogues with extended C3 ester substituents also have lower potency than amlodipine, possibly because of disruption of a favourable interaction between the protonated amino group on the 2-substituent and the DHP receptor. Replacement of the 6-methyl substituent in amlodipine by alkoxyalkyl groups or electron-withdrawing groups is also detrimental to calcium antagonist activity.
Tetrahedron Letters | 1998
David Alker; Laurence M. Harwood; C.Eleri Williams
Abstract Chiral stabilized azomethine ylids derived from reaction of (5 S )-phenylmorpholin-2-one ( 1 ) with aromatic imines undergo efficient and highly diastereocontrolled cycloaddition with a second molecule of imine to furnish products which may be converted into enantiomerically pure threo (2 S , 3 R )-3-aryl-2,3-diamino acids.
Tetrahedron Letters | 1991
David Alker; D. Neville Jones; G. Mark Taylor; William W. Wood
Abstract Efficient syntheses of homochiral, trisubstituted γ-butyrolactones via the highly stereoselective alkylation of a carbohydrate-derived γ-lactone are described.
Tetrahedron Letters | 1990
David Alker; A.G. Swanson
Abstract The structure of the product obtained by reacting the 1,4-dihydropyridine 6 with pyridinium bromide perbromide has been confirmed by NMR spectroscopy as the 2-bromomethyl derivative 7 and its reaction with a range of nucleophiles has been studied.
Tetrahedron | 1997
David Alker; Laurence M. Harwood; C.Eleri Williams
Abstract We describe the evolution of stable azomethine ylid precursors which avoid the need for an aldehyde in the ylid generation step. tert -Butyl carbamate derivative ( 16 ) demonstrates comparable efficiency to the standard method of ylid generation and trapping, but permits use of milder conditions.
Tetrahedron | 1990
David Alker; S.M. Denton
Reaction of the 2-hydroxymethyl-1,4-dihydropyridines 7 and 13 with SO2Cl2limidazole followed by treatment with nucleophiles affords 2-substituted-l,4-dihydropyridines via the intermediacy of the 2-chloromethyl compounds 14 and 18, respectively.
Journal of The Chemical Society-perkin Transactions 1 | 1990
Abdul Rashid; G. Mark Taylor; William W. Wood; David Alker
Wittig reaction of the t-butyldimethylsilylated C-3 ketone methyl 4,6-O-benzylidene-2-O-(t-butyldimethylsilyl)-α-D-ribo-hexopyranosid-3-uloside leads exclusively to C-2 alkenes, providing an efficient synthesis of these potentially useful intermediates. Alternatively, the corresponding t-butyldiphenylsilyl ether, prepared with complete regiospecificity from methyl 4,6-O-benzylidene-α-D-glucopyranoside, gives a C-3 alkene on oxidation and Wittig reaction. Deprotection, hydrogenation and cyclization of this product leads to the cis-fused butyrolactone, methyl 4,6-O-benzylidene-3-deoxy-3-(ethoxycarbonyl)-2,3-butyrolacto-α-D-allopyranoside, which is alkylated stereospecifically to give methyl 4,6-O-benzylidene-3-deoxy-3-(prop-2- yloxycarbonyl)-2,3-butyrolacto-α-D-allopyranoside. This procedure provides a general solution to the ‘off-template’ problem of carbohydrate-based natural product synthesis.
European Journal of Medicinal Chemistry | 1991
David Alker; Peter E. Cross
Abstract To evaluate the effect of introducing unsaturation into the 2-substituent of 1,4-dihydropyridines related to amlodipine ( 1 ), a number of alkene and alkyne analogues were prepared and their calcium antagonist activity was assessed. For several series of compounds, in vitro potency increased in the order alkane